Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy With 5-Fluorouracil and Oxaliplatin Versus 5-Fluorouracil Alone in Rectal Cancer
Prospective Randomised Multicenter Phase-III-study: Preoperative Radiochemotherapy and Adjuvant Chemotherapy With 5-Fluorouracil Plus Oxaliplatin Versus Preoperative Radiochemotherapy and Adjuvant Chemotherapy With 5-Fluorouracil for Locally Advanced Rectal Cancer
Sponsor: University of Erlangen-Nürnberg Medical School
Listed as NCT00349076, this PHASE3 trial focuses on Rectal Neoplasms and remains completed. Sponsored by University of Erlangen-Nürnberg Medical School, it has been updated 6 times since 2006, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE3
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE3
First recorded
Jul 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Erlangen-Nürnberg Medical School
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Altötting, Germany , Amberg, Germany , Ansbach, Germany , Bad Kreuznach, Germany , Bad Mergentheim, Germany , Bad Soden, Germany , Bad Trissl, Germany , Bayreuth, Germany , Berlin, Germany , Bielefeld, Germany and 67 more locations